{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:25:35Z","timestamp":1794918335499,"version":"4.9.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Gr\u00fcnenthal"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To study subclinical inflammation in intercritical gout patients and its relation to the estimated size of monosodium urate crystal deposition and cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a secretome analysis and the quantification of cytokine and adipokine plasma levels [IL-1\u03b2, IL-18, IL-6, soluble IL-6 receptor (sIL-6R), TNF-\u03b1, C-X-C motif chemokine 5, RANTES (Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted), leptin, resistin and adiponectin] to analyse subclinical inflammation in intercritical gout patients. Since it is currently not feasible to determinate the whole body deposit of monosodium urate crystals, we created an indirect clinical classification to estimate it. Then we compared cytokine levels in controls and gout patients and in patients with different crystal deposition sizes. We also studied the association between cytokine-levels and the number of cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety consecutive patients attending a crystal arthritis unit were studied. IL-18, sIL-6R, RANTES, leptin and adiponectin were higher in intercritical gout patients than in controls. An association was observed between IL-18, sIL6-R and RANTES levels and the size of crystal deposition. IL-18, sIL6-R, RANTES and leptin were higher in patients with no cardiovascular risk factors compared with controls with no risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results showed that the levels of some pro-inflammatory cytokines and metabolic proteins are elevated in intercritical gout patients. The levels of certain cytokines were related to the estimated size of the monosodium urate crystal deposition and to the number of cardiovascular risk factors. These cytokine changes may help to explain the increase in cardiovascular events in gout patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab335","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T07:54:16Z","timestamp":1617954856000},"page":"5463-5472","source":"Crossref","is-referenced-by-count":34,"title":["The inflammatory role of silent urate crystal deposition in intercritical gout"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6275-7699","authenticated-orcid":false,"given":"Cesar","family":"Diaz-Torne","sequence":"first","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Angels","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Immunology, Biomedical Research Institute Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garcia-Guillen","sequence":"additional","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicylle","family":"Jeria-Navarro","sequence":"additional","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Sainz","sequence":"additional","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Fernandez-Sanchez","sequence":"additional","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-6787","authenticated-orcid":false,"given":"Hector","family":"Corominas","sequence":"additional","affiliation":[{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant"},{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vidal","sequence":"additional","affiliation":[{"name":"Immunology, Biomedical Research Institute Sant Pau"},{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,11]]},"reference":[{"key":"2021110402580276100_keab335-B1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","article-title":"Epidemiology of gout: an update","volume":"24","author":"Smith","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2021110402580276100_keab335-B2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2021110402580276100_keab335-B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-017-0666-5","article-title":"Hemostasis, endothelial stress, inflammation, and the metabolic syndrome","volume":"40","author":"Grandl","year":"2018","journal-title":"Semin Immunopathol"},{"key":"2021110402580276100_keab335-B4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"2021110402580276100_keab335-B5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B8","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021110402580276100_keab335-B9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"2021110402580276100_keab335-B10","article-title":"Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy \u2013 a study using dual-energy computed tomography","author":"Chui","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2021110402580276100_keab335-B11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Care Res"},{"key":"2021110402580276100_keab335-B12","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/acr.23549","article-title":"Levels of cytokines and MicroRNAs in individuals with asymptomatic hyperuricemia and ultrasonographic findings of gout: a bench-to-bedside approach","volume":"70","author":"Estevez-Garcia","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2021110402580276100_keab335-B13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2017-212046","article-title":"Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/15257770.2015.1124999","article-title":"Ultrasonography in the diagnosis of asymptomatic hyperuricemia and gout","volume":"35","author":"Puig","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2021110402580276100_keab335-B15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10067-014-2520-7","article-title":"The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort","volume":"33","author":"Duskin-Bitan","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2021110402580276100_keab335-B16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","article-title":"Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout","volume":"66","author":"Pascual","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/art.39959","article-title":"Performance of ultrasound in the diagnosis of gout in a multicenter study: comparison with monosodium urate monohydrate crystal analysis as the gold standard","volume":"69","author":"Ogdie","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021110402580276100_keab335-B19","first-page":"812","article-title":"Effects of febuxostat on serum cytokines IL-1, IL-4, IL-6, IL-8, TNF-\u03b1 and COX-2","volume":"17","author":"Hao","year":"2019","journal-title":"Exp Ther Med"},{"key":"2021110402580276100_keab335-B20","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa920","article-title":"Crystal deposition measured with dual-energy computed tomography: association with mortality and cardiovascular risks in gout","author":"Marty-An\u00e9","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402580276100_keab335-B21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/jcm9051295","article-title":"Association of specific comorbidities with monosodium urate crystal deposition in urate-lowering therapy-naive gout patients: a cross-sectional dual-energy computed tomography study","volume":"9","author":"Pascart","year":"2020","journal-title":"J Clin Med"},{"key":"2021110402580276100_keab335-B22","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.4049\/jimmunol.1801097","article-title":"Leptin promotes monosodium urate crystal\u2013induced inflammation in human and murine models of gout","volume":"202","author":"Yu","year":"2019","journal-title":"J Immunol"},{"key":"2021110402580276100_keab335-B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bcpt.12109","article-title":"Adiponectin and leptin: new targets in inflammation","volume":"114","author":"Scotece","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2021110402580276100_keab335-B24","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021110402580276100_keab335-B25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/kes326","article-title":"Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout","volume":"52","author":"Grainger","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402580276100_keab335-B26","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.14427","article-title":"Role of immune cells in hypertension","volume":"176","author":"Caillon","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2021110402580276100_keab335-B27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000935","article-title":"A prospective follow-up of adipocytokines in cohort patients with gout: association with metabolic syndrome but not with clinical inflammatory findings: Strobe-compliant article","volume":"94","author":"Garc\u00eda-M\u00e9ndez","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2021110402580276100_keab335-B28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cyto.2005.11.010","article-title":"Plasma interleukin (IL)-18 (interferon-\u03b3-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18","volume":"33","author":"Inokuchi","year":"2006","journal-title":"Cytokine"},{"key":"2021110402580276100_keab335-B29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"2021110402580276100_keab335-B30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021110402580276100_keab335-B31","first-page":"744","article-title":"2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res","author":"FitzGerald","year":"2020"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab335\/38529290\/keab335.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5463\/41073306\/keab335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5463\/41073306\/keab335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T23:01:16Z","timestamp":1635980476000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/11\/5463\/6220331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,4,11]]},"published-print":{"date-parts":[[2021,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab335","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,11]]}}}